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Parkinson’s disease (PD) is characterized by severe motor deficits, cogwheel 
rigidity, bradykinesia, and the loss of dopaminergic neurons. The etiology of PD 
ii
has not been clearly identified; However, the final common pathway in PD 
pathogenesis leads to the excessive deposition of toxins and to misfolding of 
proteins such as α-synuclein, and failure to degrade impaired protein might lead to 
the neuronal cell death associated with PD. Autophagy is a self-degradative process 
that removes aggregated proteins, damaged organelles, and intracellular pathogens. 
Recent studies have demonstrated dysregulation of the autophagy pathway in the 
brains of PD patients and in animal models of PD, suggesting a pivotal role for 
autophagy in the pathogenesis of PD. Rotenone, a common pesticide and inhibitor 
of mitochondrial complex I, induces loss of dopaminergic neurons and 
consequential aspects of PD. In this study, the effects of natural products on 
rotenone-mediated signaling in SH-SY5Y neuroblastoma cell were investigated to 
discover new lead compounds for the treatment of PD.
Cudrania tricuspidata (Moraceae) is a subtropical tree that is widely distributed 
in Korea, China, and Japan. The fruits of C. tricuspidata are used in jams, juices, 
and a fermented alcoholic beverage with sugar, and they are commercially 
produced as food in Korea. Also, the cortex and rood bark of C. tricuspidata have 
been used as a traditional medicine for inflammation and tumors. A recent study 
demonstrated that the extracts of C. tricuspidata protect neurons against oxidative 
stress-induced cytotoxicity and have inhibitory effects on nitric oxide synthase 
(NOS). The compounds isolated from C. tricuspidata are primarily xanthones and 
flavones in addition to some alkaloids, lignins, coumarins, polysaccharides, and 
iii
chromones. The xanthones from the root bark of C. tricuspidata have been reported 
to exert protective effects against 6-OHDA-induced neurotoxicity. 
In this study, the effects of active compounds from the C. tricuspidata extracts 
on inducing autophagy were studied. Gerontoxanthone C (GXC) isolated from the 
root barks of the C. tricuspidata protected against rotenone-induced neuronal cell 
death and the collapse of mitochondrial membrane potential (MMP) through 
induction autophagy with mTOR inhibition in SH-SY5Y cells. Based on the results, 
it was suggested that GXC might be promising candidates for the therapy of 
familiar PD via facilitating recovery of damaged organelles.
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induction of autophagy with mTOR 




Parkinson’s disease (PD) is a common progressive neurodegenerative 
disorder affecting more than 6 million people worldwide. The disease is 
characterized clinically by a triad of cardinal motor symptoms including 
bradykinesia, tremors and rigidity, and pathologically by the selective loss 
of dopamine neurons in the substantia nigra pars compacta (SNpc) and the 
formation of Lewy bodies. Although the etiology of PD is still unclear, there 
is growing evidence indicating that intracellularly oxidative stress, 
mitochondrial damage, lysosomal dysfunction, neuro inflammatory changes 
and formation of pathologic inclusions contribute to the pathology of the 
disease. Treatment of PD is generally symptomatic, where levodopa remains 
the most effective agent. However, with disease progression, levodopa 
medication becomes increasingly inadequate for the management of motor 
fluctuations and dyskinesias. Levodopa given clinically undergoes auto-
oxidation and forms reactive oxygen species (ROS) which could be toxic to 
remaining dopamine neurons. Dopamine agonists and monoamine oxidase 
B inhibitors are also prescribed for the treatment of early PD as in addition 
to their symptomatic benefits they postpone the onset of levodopa therapy.
Autophagy is a self-degradative process that removes aggregated proteins, 
３
damaged organelles, and intracellular pathogens. Recent studies have 
demonstrated dysregulation of the autophagy pathway in the brains of PD 
patients and in animal models of PD, suggesting a pivotal role for autophagy 
in the pathogenesis of PD. Furthermore, there have also been several studies 
showing that autophagy enhancing leads to decreased levels of toxic 
aggregates and could show neuroprotective effects in PD models.
Rotenone, a potent mitochondrial complex I inhibitor, is one of the most 
relevant neurotoxins to induce parkinsonian symptoms. Despite debates, the 
rotenone model is able to recapitulate slow and specific loss of 
dopaminergic neurons and over-expression of alpha-synuclein and better 
mimics the clinical features of idiopathic PD. Among the various models for 
PD, the rotenone model has recently drawn particular attention for two 
reasons: 1) it reproduces most of the motor symptoms and the 
histopathological features of PD, including Lewy bodies; and 2) rotenone 
and other pesticides are powerful inhibitors of mitochondrial respiration and 
associated with the higher incidence of sporadic Parkinsonism among the 
population of rural areas. Thus, rotenone-induced parkinsonian models were 
chosen to explore the role of autophagy in PD in this study.
Cudrania tricuspidata, a small thorny tree belonging to the family 
４
Moraceae, is mainly distributed in East Asia, and its roots have long been 
used to treat contusion, hemoptysis, hematemesis, lumbago, and 
spermatorrhea. Phytochemical studies of C. tricuspidata have revealed that 
the major constituents of this plant are various types of xanthones and 
flavonoids, and these constituents have shown cytotoxic, antioxidant, 
antiatherosclerotic, anti-inflammatory, and hepato-protective activities. In a 
search to discover neuroprotective metabolites from natural products, a 
MeOH extract of C. tricuspidata showed significant protective effects 
against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in human 
neuroblastoma SH-SY5Y cells. 6-OHDA, as a neurotoxin, elicits 
dopaminergic neuronal cell death in modeling PD.
Nevertheless, to the best of our knowledge, there has been no experiment 
showing the neuroprotective effect of xanthones through enhancing the 
autophagy pathway in a PD model. Therefore, we hypothesized that 
xanthones may decrease rotenone-induced neurotoxicity in SH-SY5Y cells 
as an in vitro model of PD by modulating the autophagy signaling pathway. 
In the current study, we investigated the concentration-dependent effect of 
GXC on autophagy markers in SH-SY5Y cells and evaluated its 
neuroprotective effect. Furthermore, we evaluated which levels of the 
autophagy signaling pathway are involved in xanthones-induced autophagy 
５
modulation.
2. Material and methods 
2.1. Chemicals and reagents
Rotenone, JC-1, and CCK-8 were purchased from Sigma-Aldrich (St. Louis,
MO, USA). Dulbecco’s modified Eagle’s medium (DMEM) and fetal
bovine serum (FBS) were purchased from Gibco BRL (Rockville, MD,
USA). Hybond-polyvinylidene difluoride (PVDF) membranes were 
purchased from Amersham Pharmacia Biotechnology Inc. (Piscataway, NJ,
USA). PRO-PREP protein extraction solution and WEST-Queen® ECL 
solution were purchased from iNtRON Biotech Inc. (Kyunggi, Korea). 
Beta-actin, LC3-beta, p62, mTOR, p-mTOR, ULK1, p-ULK1, LAMP1, 
LAMP2 first antibody, secondary antibody and FITC-conjugated secondary 
antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, 
CA, USA) 
2.2. Preparation of GXC
Cudrania tricuspidata was stored at the Korea Forest Research Institute at 
Southern Forest Research Center (Jinju, Korea) in September 2008. A 
６
voucher specimen (accession number KH1-4-090814) was kept at the 
Department of Biosystems and Biotechnology at Korea University (Seoul, 
Korea). GXC was isolated from the roots of Cudrania tricuspidata and the 
structure of GXC was determined by spectroscopic methods, and the purity 
was more than 98% (Wei and Yu, 2008). GXC was dissolved in DMSO and 
diluted with PBS to obtain the proper concentration. Final concentration of 
DMSO was less than 0.1% and it didn’t influence the performed assays.
2.3. Cell cultures 
The human neuroblastoma cell line SH-SY5Y (ATCC No. CRL-2266) was 
purchased from the American Type Culture Collection (Manassas, VA, 
USA) and cultured in DMEM supplemented with 10 % heat-inactivated 
FBS and 1 % penicillin/streptomycin at 37 ºC in a humidified 5 % CO2
atmosphere. 
2.4. Measurement of cell viability
SH-SY5Y cells were seeded at a density of 1×105 cells/200 μL/well in 96-
well plates for 24 h, and the cells were treated with isolated compounds 
７
from C. tricuspidata and rotenone for 24h or 48 h. Cell viability was 
determined using a CCK-8 and measured by ELISA (Koo et al., 2011).
2.5. Measurement of MMP by JC-1 staining
SH-SY5Y cells were seeded at a density of 2×105 cells/2 mL/well in 6-well 
plates for 24 h, and the cells were pre-treated with isolated compounds for 
24 h followed by subsequent treatment with rotenone (0.5 μM) for an 
additional 2 h. MMP was determined using a JC-1 dyes. Briefly, the cells 
were washed with PBS, and then incubated with 10 µg/mL of JC-1 for 30 
min at 37 ºC in the dark. The cells were then washed with PBS. The 
fluorescence intensities were measured by flow cytometry (BD 
FACSCalibur TM).
2.6. Measurement of protein expression 
The cells were collected, washed with PBS and lysed with a PRO-
PREP protein extraction solution at -20 ºC for 20 min. After centrifugation 
at 13,000 x g for 30 min, the supernatant was used as the total protein 
extracts. Western blot analysis was accomplished as previously described 
８
method (Ham et al., 2013).
2.7. Measurement of autophagy by fluorescence microscope
The culture dish was coated with 0.2 % gelatin at 37 °C for 30 min and 
dried at RT on a clean bench. The SH-SY5Y cells were plated at a density of 
5×104 cells/200 μL/well in coated dishes and treated with isolated 
compounds from C. tricuspidata and rotenone for 24 h. After treatment, the 
cells were washed with 1x PBS/Tween-20 buffer (pH 7.4) (PBST) once. The 
cells were fixed with 4 % paraformaldehyde for 30 min at room temperature 
(RT). After washing with PBST, the blocking steps were performed with 1 % 
BSA in PBST. Next, the cells were incubated with the primary antibody at 
4 °C overnight. The next day, the cells were washed with PBST 3 times and 
incubated with FITC-conjugated secondary antibody for 1 h at RT. After 1 h, 
the cells were washed with PBST 3 times, and DAPI staining was 
performed for 5 min at RT. Lastly, the PBST washing and mounting steps 
were conducted.
2.8. Statistical analysis 
９
All experimental data are expressed as mean value ± standard deviation. 
Statistical significance between multiple groups was determined by one-
way ANOVA (PRISM Graph Pad, San Diego, CA, USA). When ANOVA
had a significant difference, post hoc Bonferroni’s multiple comparison tests




3.1. Protective effect of GXC on rotenone-induced cytotoxicity
The isolated compounds from C. tricuspidata were evaluated to determine 
its protective effects on rotenone-induced cell death. As shown in Table 1, 
five isolated compounds protected rotenone-induced cell death. Among 
three isolated compounds, GXC showed potent neuroprotective effects on 
rotenone-induced cytotoxicity with an EC50 values of 5.6 μM. GXC protect 
rotenone-induced cell death concentration-dependently manner (Fig. 2). 
１１
Figure 1. Chemical structure of GXC
１２
Table 1. Protective effect of isolated compounds from C.tricuspidata on 
rotenone-induced cytotoxicity







1 TH1-116-2K (TH1) >50 22 TH3-165-4K (TH22) >50
2 TH1-116-3K (TH2) >50 23 TH3-185-1 (TH23) >50
3 TH3-23-5 (TH3) >50 24 TH4-3-3 (TH24) >50
4 TH3-33-2K2 (TH4) >50 25 TH4-5-2 (TH25) >50
5 TH3-33-3K1 (TH5) >50 26 TH4-7-2K2 (TH26) >50
6 TH3-33-4 (TH6) >50 27 TH4-103-1 (TH27) >50
7 TH3-33-5K1 (TH7) >50 28 TH4-105-4K (TH28) >50
8 TH3-77-4 (TH8) >50 29 TH4-105-5 (TH29) >50
9 TH3-83-2 (TH9) >50 30 TH4-105-7K (TH30) >50
10 TH3-83-5 (TH10) >50 31 TH4-109-1 (TH31) >50
11 TH3-83-7 (TH11) >50 32 TH4-109-4 (TH32) >50
12 TH3-87-2 (TH12) >50 33 TH4-109-6 (TH33) >50
13 TH3-103-1K2 (TH13) >50 34 TH4-121-4 (TH34) >50
14 TH3-105-1 (TH14) >50 35 TH4-123-3 (TH35) >50
15 TH3-105-4 (TH15) >50 36 TH4-123-6 (TH36) >50
16 TH3-105-5 (TH16) >50 37 TH4-123-7K1 (TH37) >50
17 TH3-107-1K (TH17) >50 38 TH4-123-8 (TH38) >50
18 TH3-109-1 (TH18) >50 39 TH4-127-6 (TH39) >50
19 TH3-125-2 (TH19) >50 40 TH4-129-2 (TH40) >50
20 TH3-125-4 (TH20) >50 41 TH4-131-2 (TH41) >50
21 TH3-131-4K (TH21) >50 42 TH4-131-4 (TH42) >50
１３
Table 1. Continued







43 TH4-133-11K (TH43) >50 64 TH5-3-2K3 (TH64) >50
44 TH4-133-12 (TH44) >50 65 TH5-3-4K (TH65) >50
45 TH4-133-13K (TH45) >50 66 TH5-3-5K (TH66) >50
46 TH4-139-7K2 (TH46) >50 67 TH5-3-6K (TH67) >50
47 TH4-139-8 (TH47) >50 68 TH5-9-2K1 (TH68) >50
48 TH4-141-9 (TH48) >50 69 TH5-11-4 (TH69) >50
49 TH4-165-3K (TH49) >50 70 TH5-15-2K3 (TH70) >50
50 TH4-165-7 (TH50) >50 71 TH5-15-4K (TH71) >50
51 TH4-165-8 (TH51) >50 72 TH5-17-5 (TH72) >50
52 TH4-173-3 (TH52) >50 73 JY1-82-3 (JY1) >50
53 TH4-179-1K (TH53) >50 74 JY1-91-3 (JY2) >50
54 TH4-179-4K2 (TH54) >50 75 JY1-111-1 (JY3) >50
55 TH4-179-7K2 (TH55) >50 76 JY1-115-1 (JY4) >50
56 TH4-195-2K (TH56) >50 77 JY1-130-4 (JY5) >50
57 TH4-197-1K2 (TH57) >50 78 JY1-132-3 (JY6) >50
58 TH4-197-2K3 (TH58) >50 79 JY1-62-1 (JY7) >50
59 TH4-199-1K1 (TH59) >50 80 JY1-64-4 (JY8) >50
60 TH4-199-1K2 (TH60) >50 81 JY1-64-5 (JY9) >50
61 TH4-199-2K1 (TH61) >50 82 JY1-64-7 (JY10) >50
62 TH4-199-2K2 (TH62) >50 83 JY1-88-13 (JY11) >50
63 TH5-3-2K1 (TH63) >50 84 JY1-89-8 (JY12) >50
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Table 1. Continued
Cell viability EC50 value(μM) Cell viability EC50 value(μM)
No. Code ROT EC50 No. Code
ROT 
EC50
85 JY1-164-5 (JY13) >50 108 JY1-179-8 (JY36) >50
86 JY1-99-1 (JY14) >50 109 JY1-179-9 (JY37) >50
87 JY1-99-2 (JY15) >50 110 JY1-180-4 (JY38) >50
88 JY1-101-1 (JY16) >50 111 JY1-180-7 (JY39) >50
89 JY1-101-4 (JY17) >50 112 JY1-180-10 (JY40) >50
90 JY1-102-4 (JY18) >50 113 JY1-181-3 (JY41) >50
91 JY1-104-3 (JY19) >50 114 JY1-181-4 (JY42) >50
92 JY1-120-3 (JY20) >50 115 JY1-181-5 (JY43) >50
93 JY1-146-1 (JY21) >50 116 JY1-181-7 (JY44) >50
94 JY1-153-2 (JY22) >50 117 JY1-181-8 (JY45) >50
95 JY1-154-2 (JY23) >50 118 JY1-182-3 (JY46) >50
96 JY1-158-2 (JY24) >50 119 JY2-182-4 (JY47) >50
97 JY1-162-1 (JY25) >50 120 JY1-184-9 (JY48) >50
98 JY1-164-4 (JY26) >50 121 JY1-188-4 (JY49) >50
99 JY1-165-8 (JY27) 13.8 122 JY1-189-1 (JY50) >50
100 JY1-166-3 (JY28) >50 123 JY1-190-1 (JY51) >50
101 JY1-167-6 (JY29) >50 124 JY1-190-16 (JY52) >50
102 JY1-168-6 (JY30) >50 125 JY1-191-3 (JY53) >50
103 JY1-170-5 (JY31) >50 126 JY1-193-2 (JY54) >50
104 JY1-170-6 (JY32) >50 127 JY1-193-3 (JY55) >50
105 JY1-172-2 (JY33) >50 128 JY1-134-4 (JY56) 6.5
106 JY1-173-1 (JY34) >50 129 Gerontoxanthone C (GXC) 5.6
107 JY1-179-6 (JY35) >50
１５
Figure 2. Protective effect of GXC on rotenone-induced cytotoxicity in 
SH-SY5Y cells
Cells were cultured in 96-well plate for 24 h, and GXC(1-20μM) were 
simultaneously treated with rotenone (0.5 µM) for 24 h or 48 h. Cell 
viability were measured by CCK-8 assay. Deta represent the mean ± SD of 
three independent experiments. 
Rotenone 0.5μM Rotenone 0.5μM
１６
3.2. Protective effect of GXC on rotenone-induced collapse of MMP
The three isolated compounds which protected rotenone-induced cytotoxicity 
(Table 1) were also evaluated to determine its protective effects on rotenone-
induced collapse of MMP. Rotenone induces the rapid collapse of MMP in 
SH-SY5Y cells. In our results, rotenone-induced collapse of MMP was 
peaked at 2 hours after treatment rotenone 0.5μM. To evaluate the effect of 
compounds on MMP, SH-SY5Y cell were pre-treated by GXC for 24h. After 
then, MMP was disrupted by rotenone. As shown in Table 2, three isolated 
compounds protected rotenone-induced collapse of MMP. Among three
isolated compounds, GXC showed potent neuroprotective effects on 
rotenone-induced MMP collapse with an EC50 values of 6.9 μM. GXC
protect rotenone-induced MMP collapse concentration-dependent manner 
(Fig. 3).
１７
Table 2. Protective effect of isolated compounds from C.tricuspidata on 
rotenone-induced collapse of MMP
MMP EC50 value(μM)
No. Code ROT-induced EC50
1 JY1-165-8 (JY27) 14.79
2 JY1-134-4 (JY56) 6.85
3 Gerontoxanthone C (GXC) 6.9
１８
Figure. 3 Protective effect of GXC on rotenone-induced collapse of 
MMP in SH-SY5Y cells
The cells were pre-treated with different concentrations of GXC (1 - 20 μM) 
for 24 h and subsequently treated with rotenone (0.5 μM) for another 2 h. 
The cells were stained with JC-1 dyes for 30 min and determined by FACS
analysis using FL-1 and FL-2 channel. The values of fluorescence intensity 
were obtained from histogram statistic of CellQuest software. (A) The cells 
Rotenone 0.5μM 2h








were pre-treated with different concentrations of GXC (20 μM) for 24 h and 
subsequently treated with rotenone (0.5 μM) for another 2 h. The cells were 
stained with JC-1 dyes for 30 min and determined by confocal microscopy.
Mitochondrial depolarization is indicated by a decrease in the red/green 
fluorescence intensity ratio. Cellular morphologies were visualized with a 
fluorescence microscope (×400). Representative images from three 
independent experiments are shown. (B)
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3.3. Inhibition effects of treatment with GXC alone on mTOR activity
mTOR has been known as a key regulator of autophagy. The residual 
mTORC1 activity may prevent Ulk1 activation by phosphorylation at S757, 
thus minimizing autophagy initiation. Conditions that inhibit mTORC1, 
enhanced the activity of ULK1 complex (ULK1-Atg13-FIP200) and 
triggered autophagy. We evaluated mTOR, ULK-1 protein expression in 
SH-SY5Y cells. GXC inhibited mTOR protein activity time and
concentration dependently. GXC also decreased phosphorylation(S757) of 
ULK1 time and concentration dependently. (Fig. 4)
２１
Figure 4. Inhibitory effect of GXC on mTOR activity in SH-SY5Y cells
The cells were treated with GXC for different durations (0 - 48 h, 20 μM) 
and concentrations (0-20 μM, 24 h). After treatment, the total protein was 
extracted and determined protein expression level by western blot assay. 




3.4. Effects of treatment with GXC alone on intracellular signaling 
proteins associated with autophagy
Microtubule-associated protein 1A/1B-light chain 3 (LC3) is an 
autophagosome marker. The conversion of the soluble form (LC3-I) in the 
cytosol to the autophagosome-bound form (LC3-II) indicates an increase in 
autophagosome formation, which is typically proportional to the increase in 
autophagic flux. LC3-binding protein, p62 is also used as a marker to 
monitor autophagosome. We evaluated LC3, p62 protein expression in SH-
SY5Y cells. The expression of LC3 and p62, markers of autophagosome 
formation, increased after treatment with GXC alone, in a time- and 
concentration-dependent manner. (Fig. 5)
２３
Figure 5. Effect of GXC on LC3, p62 protein expression in SH-SY5Y 
cells
The cells were treated with GXC for different durations (0 - 48 h, 20 μM) 
and concentrations (0-20 μM, 24 h). After treatment, the total protein was 
extracted and determined protein expression level by western blot assay. 
Representative data from three independent experiments are shown.
A B
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3.5. Effects of GXC on levels of intracellular signaling proteins 
associated with autophagy in rotenone-induced neurotoxicity
Treatment of SH-SY5Y cells with 0.5 μM rotenone alone didn’t effect on 
mTOR expression and ULK1 expression. However, treatment with the 
combination of rotenone + GXC (2.5, 5, 10 or 20 μM) decreased the activity 
of mTOR and ULK1, which is an upstream autophagy pathway marker in a 
concentration-dependent manner (Fig. 6). The levels of LC3-II and the 
levels of p62, a standard marker of autophagy, increased significantly in a 
concentration-dependent manner when treated with the combination of 
rotenone and GXC (Fig. 7). We also used fluorescence microscopy to 
evaluate accumulation of LC3-II, which implies the formation of 
autophagosome. The accumulation of LC3-II increased after treatment of 
GXC (20μM) alone and treatment of GXC (20μM) with rotenone(0.5μM)
(Fig. 8).   
２５
Figure 6. Effects of GXC on mTOR activity in SH-SY5Y cells with 
rotenone treatment
The cells were treated with GXC for different concentration (0-20 μM) with 
rotenone (0.5 μM) for 24 h. After treatment, the total protein was extracted 
and determined protein expression level by western blot assay. 
Representative data from three independent experiments are shown.
２６
Figure 7. Effects of GXC on LC3 and p62 expression in SH-SY5Y cells 
with rotenone treatment
The cells were treated with GXC for different concentration (0-20 μM) with 
rotenone (0.5 μM) for 24 h. After treatment, the total protein was extracted 
and determined protein expression level by western blot assay. 
Representative data from three independent experiments are shown.
Rotenone(0.5μM)
２７
Figure 8. Effects of GXC on autophagosome formation in SH-SY5Y 
cells with or without rotenone treatment 
The cells were treated with rotenone(0.5μM) alone, GXC(20μM) alone, and 
rotenone(0.5μM)+GXC(20μM) for24h. Cells were fixed and the nuclei were 
visualized with DAPI staining. LC3 was detected by immunostaining was 
analyzed and compared with control. Puncta represent autophagosome 
formation. Cellular morphologies were visualized with a fluorescence 
microscope (×400). Representative images from three independent 
experiments are shown.
２８
3.6. GXC prevents rotenone-induced cytotoxicity in an autophagy-
dependent manner
Bafilomycin A1 is a known inhibitor of the late phase of autophagy. It 
prevents maturation of autophagic vacuoles by inhibiting fusion between 
autophagosomes and lysosomes. Bafilomycin A1 acts by inhibiting vacuolar 
H+- ATPase (V-ATPase). As shown in Fig. 9, GXC (20μM) rescued 
rotenone-induced cell death and this effect was prevented by bafilomycin 
A1(20nM). 
２９
Figure 9. The protective effect of resveratrol against rotenone-induced 
neurotoxic apoptosis is associated with autophagy
SH-SY5Y cells treated with/without 20 μM GXC for 48 h were treated 
with/without 0.5 μM rotenone in the presence/absence of 20 nM 




PD is the most common neurodegenerative movement disorder. The 
primary pathogenesis of PD includes progressive degeneration of 
dopaminergic neurons in substantia nigra. Furthermore, Lewy bodies, 
abnormal aggregates of protein that are primarily composed of ɑ-synuclein, 
have been identified as a distinctive feature of the disorder. Misfolded 
proteins in PD are degraded via the following two pathways. The ubiquitin-
proteasome sys-tem (UPS) selectively degrades short-lived intracellular and 
plasma membrane proteins under basal metabolic conditions. In contrast, the 
autophagy-lysosome system (ALS) degrades long-lived, stable proteins, and 
this is the only pathway that can recycle large organelles such as 
mitochondria.
In our study, human SH-SY5Y cells exposed to rotenone were used as an 
in vitro model of PD to explore the effects of GXC on rotenone 
neurotoxicity and its underlying mechanisms. These findings indicated that 
GXC could attenuate cell apoptosis and MMP decrease induced by rotenone. 
Moreover, the protective effects were partially blocked upon treatment with
autophagy inhibitors such as bafilomycin A1. 
The induction of autophagy by the inhibition of mTOR complex 1 
３１
(mTORC1) is conserved from yeast to mammals and acts upstream of the 
UNC51-like kinase 1 (ULK1) complex. Compared with control group, the 
expression of p-mTOR and p-ULK1 was decreased by GXC treatment, 
showing that GXC inhibited mTOR activity. Also, the ratio of LC3-II/I was 
elevated by GXC, showing that GXC induced autophagy in SH-SY5Y cells. 
In the present study, bafilomycin A1 was used to inhibit autophagosome-
lysosome fusion, which prevented GXC -induced inhibition of cell death 
and GXC-induced acidic vesicular organelle formation. This suggests that 
GXC attenuates neurotoxicity through increased autophagolysosome 
formation.
Autophagy defects can occur at different stages of the pathway in 
different diseases, and this may influence treatment strategies. Defects in 
autophagosome formation may be amenable to drugs that enhance 
autophagosome biogenesis mTOR inhibitors may therefore be beneficial in 
this context. In conclusion, we demonstrated the neuroprotective effect of 
GXC in SH-SY5Y cells against rotenone-induced neurotoxicity and MMP 
collapse, with inhibition of mTOR activity. The mechanism of 
neuroprotection is likely to be associated with increased autophagy. The 
neuroprotective effect of GXC on rotenone-induced dopaminergic 
３２
neurotoxicity via modulation of autophagy provides a new therapeutic 
strategy for the treatment of PD.
5. Conclusion
In conclusion, this study demonstrated that GXC protected against 
rotenone-induced neuronal cell death and collapse of MMP in SH-SY5Y 
cells. Our results showed that GXC alone increased ULK1 activity by 
inhibiting mTOR activity, upstream autophagy pathway, and increased LC3-
II and p62, autophagy associated proteins. Also, GXC inhibits mTOR and 
ULK1 activity, and increased LC3-II and p62 in rotenone-induced 
neurotoxicity. However, the neuroprotective effect of GXC was inhibited by 
bafilomycin A1, suggesting their neuroprotective effect is partly due to the 
induction of autophagy. Based on our results, we suggest that GXC might be 
promising candidates for the therapy of PD via inducing autophagy.
３３
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국문초록
Rotenone으로 유도한 Parkinson’s disease 
model에서 mTOR 억제로 유도된 autophagy에





파킨슨병 (PD)은 심한 운동 능력 결핍, 근육의 경직, 운동완만증 및
도파민성 신경 세포의 소실을 특징으로 한다. PD의 병인은 명확하게 밝
혀지지 않았다. 그러나 PD 병인의 마지막 공통 경로는 독소의 과도한
축적과 α-synuclein과 같은 단백질의 잘못 접힘을 초래하고, 손상된 단
백질을 분해하지 못하면 PD와 관련된 신경 세포의 죽음을 초래할 수 있
다. Autophagy는 응집 된 단백질, 손상된 세포 기관 및 세포 내 병원균
４５
을 제거하는 자기 분해 과정이다. 최근 연구에 따르면 PD 환자의 뇌와
PD의 동물 모델에서 autophagy 경로의 조절 장애가 입증되어 PD의 병
인에 있어 autophagy의 중추적 역할을 시사하고있다. 일반적인 살충제
이자 미토콘드리아 complex I의 억제제인 rotenone은 도파민성 뉴런의
손실 및 PD의 결과적인 측면을 유도한다. 본 연구에서는 SH-SY5Y 신
경모세포종 세포에서 rotenone 관련 기전에 대한 천연물의 영향을 조사
하여 PD 치료를 위한 새로운 리드 화합물을 발견했다.
Cudrania tricuspidata (뽕나무과)는 한국, 중국 및 일본에 널리 분포
하는 아열대 식물이다. C. tricuspidata의 열매는 잼, 주스 및 설탕과 함
께 발효 된 알코올 음료에 사용되며, 한국에서 식품으로 상업적으로 생
산된다. 또한 C. tricuspidata의 피층과 뿌리의 껍질은 염증과 종양에 대
한 전통 의학으로 사용되어왔다. 최근의 연구에 따르면 C. tricuspidata
의 추출물은 산화 스트레스에 의해 유발 된 세포 독성으로부터 뉴런을
보호하고 산화 질소 합성 효소 (NOS)에 대한 억제 효과가 있음이 입증
되었다. C. tricuspidata로부터 분리 된 화합물은 일부 alkaloids, lignins, 
coumarins, polysaccharides, 그리고 chromones이고, 주로 xanthones 
and flavones이다. C. tricuspidata의 뿌리 껍질에서 유래 한 xanthones
의 6-OHDA로 유발된 신경 독성에 대한 보호 효과가 보고되었다. 
４６
본 연구에서는 C. tricuspidata 추출물의 활성 성분이 autophagy 유도
에 미치는 영향을 연구했다. C. tricuspidata의 뿌리 껍질로부터 분리된
Gerontoxanthone C (GXC) 은 SH-SY5Y 세포에서 mTOR 억제를 통해
autophagy를 유발함으로써 rotenone으로 유도된 신경 세포 사멸 및 미
토콘드리아 막 전위 (MMP)의 붕괴를 보호했다. 결과를 토대로, GXC는
손상된 세포 기관의 회복을 촉진하여 PD의 치료에 대한 유망한 후보 물
질이 될 수 있음을 시사한다.
주요 단어: 파킨슨병, PD, 신경 보호, autophagy, mTOR, Cudrania
tricuspidata
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